←Back to Expert Scholars
Translational Medicine / 转化医学HPV-Negative Head and Neck Cancer
Barbara Burtness
MD
🏢Yale Cancer Center🌐USA
Professor of Medicine
60
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Barbara Burtness has been a key investigator on KEYNOTE-048 and other pivotal immunotherapy trials in head and neck cancer. Her research specifically addresses the challenging HPV-negative subgroup where outcomes remain poor despite immunotherapy. She leads biomarker-driven treatment strategies at Yale Cancer Center.
Share:
🧪Research Fields 研究领域
HPV-negative HNSCC
KEYNOTE-048
Immunotherapy
Cetuximab
Biomarker studies
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Barbara Burtness 的研究动态
Follow Barbara Burtness's research updates
留下邮箱，当我们发布与 Barbara Burtness（Yale Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment